BACK TO TOP
AGICC: The Academic GI Cancer Consortium

 

About Us

MISSION AND VALUES

Mission

To bring together the best minds in GI cancer research to expedite the discovery and efficient testing of active new compounds for the treatment of GI cancers, enabling sponsors to bring efficacious new drugs to the market to advance the state of care for GI cancer patients.

 

Objectives

The Academic GI Cancer Consortium's primary objectives include:

Advance clinical and translational research in gastrointestinal malignancies through a Consortium of institutions and investigators with expertise in the natural history and molecular biology of GI cancers.

Create an effective model for privately funded clinical and translational research in GI cancers.

Rapidly and efficiently test the efficacy of compounds in development as anti-cancer agents through innovative Phase I and II trials, with the goal of increasing the number of useful compounds available to treat patients with advanced gastrointestinal malignancies.

GET TO KNOW US!

DOWNLOAD OUR BROCHURE